Financials

Financials — What the Numbers Say

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Shakti Pumps is a small-to-mid-cap Indian pump and motor maker that became a tendered government-scheme play. Revenue more than doubled from $118M in FY23 to $294M in FY25 on the back of PM-KUSUM solar-pump tenders, and operating margins re-rated from 7% to 24%. FY26 is the cool-down: revenue grew only 7% to $288M (in dollar terms; the rupee weakened across the period), operating margin compressed back to 16%, and net profit fell to $27.5M from $47.7M. Cash conversion has deteriorated sharply — operating cash flow of $13M against $27M of reported net income — because receivables now sit at roughly $185M (Sep 2025) and the company is mid-cycle on a ~$135M capex plan that doubled pump/motor capacity and built a 2.2 GW solar cell + PV module plant. Net debt has risen from near-nil to roughly $52M of gross debt, financed by a fresh equity raise that took share capital from $2M to $14M (FY24→FY25 bonus/QIP) and added another $58M of net financing inflow in FY26. The valuation setup is mid-cycle: 26x trailing earnings against a peer band of 17x–57x and a 4.0x book against a sub-segment range of 3.4x–9.5x. The single financial metric that matters most right now is the receivables balance and its conversion to cash — that is the bridge between an "earnings-quality concern" and a "real solar-pump compounder" thesis.

A note on terminology. All figures shown in U.S. dollars at period-end FX rates. Operating margin is operating profit divided by revenue. Free cash flow (FCF) is cash from operations minus capex (we use cash from investing as the proxy here). ROCE is return on capital employed — operating profit on debt + equity. D/E is total debt divided by shareholders' equity.

Revenue, Margins, and Earnings Power

For a decade Shakti was a sub-$80M revenue, mid-teens-margin commodity-pump exporter that posted a small loss in FY20 and a recovery to FY21. The transformation began in late FY24 when central and state PM-KUSUM solar pump tenders moved from pilot to scale. Revenue went from $118M in FY23 to $294M in FY25 — a 2.5x in two years (the rupee weakened over the period, so the rupee growth was even larger) — and operating profit went 9x from $8M to $71M.

The chart that matters more than any other here is the quarterly trajectory — because the FY26 annual number masks a sharp Q3/Q4 deceleration.

Two facts to anchor: revenue ramped 4x in three quarters from Q3FY24 onwards as solar-pump volumes scaled, and margins doubled from 11% to a 24% peak as fixed-cost absorption improved. Both reversed in H2 FY26: Q3FY26 revenue dropped 17% sequentially to $61M and operating margin fell to 11%; Q4FY26 saw revenue back at $92M but margins stuck at 10%. Management on the Q2FY26 call attributed the weakness to extended monsoon, GST 2.0 transition, and a 3–4% increase in copper, steel and solar-panel input costs — but the size of the margin compression suggests scheme-execution drag and competitive pricing pressure as new entrants scale, not just input cost inflation.

Cash Flow and Earnings Quality

This is where the FY26 story becomes uncomfortable. Free cash flow — cash generated by operations after the capex needed to run the business — has been chronically below net income. The company has reported about $92M of cumulative net income across FY24–FY26 against roughly $22M of cumulative operating cash flow. Reported earnings are real, but a large share is locked up in receivables and inventory tied to government tenders.

The OCF/NI ratio shows two windows of healthy cash conversion (FY21 post-Covid restocking, and FY17/FY23) and a structural deterioration once PM-KUSUM tenders dominated the mix. Debtor days — days of revenue tied up in receivables — climbed from 92 days in FY23 to 178 days in FY24, and remain at 173 days in FY26. Management's own commentary frames roughly 10% of receivables as retention money against RMS (remote monitoring system) data, with the balance dependent on extended monsoon-to-installation timing and state-tender release cycles. Until receivables compress to the company's own 120-day target, the gap between reported earnings and shareholder cash will persist.

A final earnings-quality flag: the FY26 effective tax rate is 28% in the annual data but Q4FY26 alone shows a 42% effective rate, suggesting one-off tax charges that mechanically depressed reported PAT in the final quarter.

Balance Sheet and Financial Resilience

For most of the past decade Shakti carried modest debt ($10–25M) and middling equity. The FY24–FY26 transformation rebuilt both sides of the balance sheet at once: equity grew from $91M (FY24) to $182M (FY26) on retained earnings and a fundraise that lifted share capital from $2M to $14M, while gross debt jumped from $10M to $52M to fund the ~$135M capex programme.

The leverage picture is much less alarming than the cash-flow picture. Even at the higher FY26 debt level, D/E sits at 0.29x — well within investment-grade norms for an industrial — and interest coverage is 7.2x. The fund-raise added to total equity, so absolute solvency is comfortable. The risk is liquidity, not solvency: roughly $185M of receivables (vs ~$8M of fixed assets and ~$31M of "other assets" likely including inventory and cash) creates a brittle working-capital structure. If a state tender execution slips by a quarter, the company has to either draw more debt or slow capex.

Returns, Reinvestment, and Capital Allocation

Returns spiked in FY25 — ROCE 55%, ROE 35% — because the operating profit jump ($27M → $71M) outran the equity base growth. Both metrics retrenched in FY26 as margin normalised and the equity base re-set higher. The longer 10-year picture shows ROCE oscillating between near-zero (FY20 Covid loss) and 30%+ peaks, a cyclicality that has more in common with tender-cycle EPC plays than with branded consumer-pumps compounders like KSB.

The capital-allocation chart tells the cleanest version of the story. From FY21 to FY23 the company was effectively self-funding (low capex, debt repayment). FY24 and FY25 marked the transition: capex jumped to $7M then $23M, and external financing — a QIP that took promoter holding from 56.2% to 51.6% — funded the growth-asset build. FY26 raised the stakes: $30M of capex outflow and $58M of net financing inflow (a mix of debt and a smaller secondary issue that drove promoter holding to 50.4%). Share count is up roughly 12% over three years.

Management's framing is that the ~$135M capex programme will support roughly $340M of incremental annual revenue at 15% EBITDA margin, implying about $51M of incremental EBITDA. At face value that is an attractive ~37% pre-tax IRR on capex. The catch is execution: the new 2.2 GW solar cell + PV module plant pulls Shakti into a more competitive, lower-margin segment than its core pump-and-motor business, and the 15% EBITDA guide is below recent group margins of 20–25%. Capital is being reinvested at returns that are likely good but lower than the operations they augment.

Dividend payout has fallen from a 13–20% range pre-FY22 to 3–6% in FY24–FY26 — a deliberate redirection of cash to growth capex and a clear signal that management views reinvestment as the better marginal use of every dollar.

Segment and Unit Economics

Detailed segment profitability is not disclosed in the consolidated filings (segment.json is empty), but management commentary and product disclosures are sufficient to triangulate the mix.

Solar pumps remain the cornerstone — 39,861 installations in H1FY26 (a 19% YoY increase) and a roughly $145M order book at 7 November 2025. Exports added $11M in Q2FY26 and $22M in H1FY26, growing in importance. Retail (consumer-facing pumps via 100+ exclusive outlets) ran $4.7M in Q2FY26, up 67% YoY but still small. Solar rooftop EPC is in launch phase (57 channel partners signed) and is not yet a meaningful revenue contributor.

The honest read: ~70%+ of FY26 revenue ties back to government solar-pump tenders. That single dependence is what makes the receivables, working-capital, and margin discussion above all the same problem stated three different ways. Diversification away from this concentration is the single highest-impact financial improvement available to the company.

Valuation and Market Expectations

At a closing price of $5.82 on 8 May 2026 against TTM EPS of $0.22, Shakti trades at 26.4x trailing earnings and 4.0x book value. The same multiples on FY25 peak earnings (EPS $0.40) are 16.2x and 4.0x. EV/Sales is roughly 2.5x against TTM revenue of $288M.

The stock has retraced roughly 60% from the September 2024 peak of ~$17 to $5.82, while EPS is down ~40% from the FY25 peak — meaning the de-rating is approximately one-third multiple compression and two-thirds earnings cut. The market has already priced in some of the FY26 disappointment.

Shakti now trades at a discount to KSB, Kirloskar Brothers, Roto and WPIL on P/E, but at a premium to Oswal. The discount to the diversified industrial peers looks deserved on three dimensions: scheme concentration, working-capital risk, and weaker cash conversion. It is unjustified on growth (Shakti's 3-year revenue CAGR of ~40% is the highest in the peer set) and capacity build (the only peer with a comparable $100M+ growth-capex programme is Oswal). The mid-pack 4.0x book is harder to defend — KSB and Kirloskar Brothers earn 18–22% ROEs that mechanically support 6–9x P/B, but Shakti's normalised-through-cycle ROE is closer to 15%, which on a Gordon-growth basis supports ~3.5x book.

Bear / base / bull scoping (illustrative, not a model):

Scenario	Setup	Rough fair value
Bear	FY27 EPS at $0.17 (further margin compression to 12%, debtor write-down), 12x	$2.00
Base	FY27 EPS at $0.26 (margin recovery to 18%, growth resumes 15%+), 22x	$5.80
Bull	FY27 EPS at $0.37 (full-year benefit of new capacity, 22% margins), 26x	$9.60

The current price is roughly aligned with the base case. The valuation is fairly priced relative to a normalised earnings stream and discounts the FY26 setback. It is not cheap — the market is paying a premium for solar-pump market position on a depressed earnings base.

Peer Financial Comparison

The peer set is informative because it spans three business archetypes. KSB and Kirloskar Brothers are diversified, branded, multi-decade pump-and-valve houses earning steady mid-teens margins and 20%+ returns — the market awards KSB ~55x and Kirloskar ~33x P/E for predictability and lack of single-customer concentration. Oswal is the closest pure comparable (also a vertically-integrated solar-pump maker, also a recent listing) and its 29% margin and 80%+ ROCE highlight what Shakti looked like at peak FY25 — yet Oswal trades at only ~13x because its concentration risk is even more acute and its post-IPO float is small. WPIL and Roto are mid-tier hybrids that trade in a 35–36x band. Shakti's 26x sits below the diversified peers and above the closest single-product peer — exactly where a tender-driven mid-cycle player with a credible diversification story should sit. What it doesn't do is offer a margin of safety: the multiple is fair, not cheap.

What to Watch in the Financials

Metric	Why it matters	Latest value	Better	Worse	Where to check
Debtor days	Direct gauge of receivables backlog and cash conversion	173 days (FY26)	Under 120 days (mgmt target)	Above 180 days	ratios.json
Operating cash flow / net income	Earnings quality — are reported profits real cash?	48% (FY26)	Above 80%	Under 40%	cash_flow.json
Operating margin	Tracks scheme-execution health and input-cost pressure	16% (FY26 full year), 10% (Q4FY26)	Above 18% sustained	Under 14% sustained	income_quarterly.json
Order book ($M)	Forward revenue cover; tender pipeline strength	~$145M (Nov 2025)	Above $200M	Under $115M	quarterly transcripts
Net debt	Funding gap if receivables stay stretched	~$52M gross debt (FY26)	Falls as receivables release	Rises further	balance_sheet.json
New-capacity revenue contribution	Validates the ~$135M capex thesis	$0 disclosed	$55M+ in FY27	Slipped beyond FY28	quarterly disclosures
Promoter shareholding	Signals further dilution risk	50.4% (Mar 2026)	Stable	Falls below 50%	shareholding.json

What the financials confirm: Shakti has executed a meaningful transformation in scale and profitability, and the business it has built is a real one with structural tailwinds from solar-pump electrification. What they contradict: the easy "clean compounder" narrative — earnings quality is only fair, working capital is intense, and the FY25 peak margins are not the new baseline. The crucial ambiguity for FY27 is whether margin compression is cyclical (tender mix, monsoon, GST 2.0) or structural (competition from Oswal and others, scheme winding down).

The first financial metric to watch is cash collected from receivables in Q4FY26 / Q1FY27. Management has guided to substantial release in the December 2025 quarter; if reported operating cash flow for full FY26 lands materially above $45M, the bull case strengthens; if it stays near $15M, the working-capital concern becomes a balance-sheet concern and the equity story will need a heavier valuation discount than the current 26x P/E reflects.